Blueprint Medicines Corporation
USD129.46
+0.18 (+0.14%)
CEO
Kathryn Haviland
IPO Date
2015-04-30
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$129.46
Prev. Close
$129.28
Day Low
$129.46
Day High
$129.46
52W Low
$73.04
52W High
$129.55
Market Cap
$8.36B
Volume
2.98M
| -11.0 |
| 31 Dec 2022 | FY | 91.3% | -273.2% | -108.3% | -41.3% | 0.47 | 5.71 | -4.7 |
| 31 Dec 2021 | FY | 90.0% | -357.7% | -66.4% | -51.4% | 0.11 | 3.70 | -9.7 |
| 31 Dec 2020 | FY | 99.9% | 39.5% | 21.4% | 18.3% | 0.06 | 7.09 | 19.5 |
| 31 Dec 2019 | FY | 100.0% | -494.2% | -70.8% | -46.4% | 0.21 | 4.85 | -11.7 |
| 31 Dec 2018 | FY | -447.2% | -531.5% | -56.5% | -43.8% | 0.03 | 8.29 | -10.0 |
| 31 Dec 2017 | FY | -575.3% | -691.3% | -23.7% | -20.7% | 0.03 | 15.98 | -19.2 |
| 31 Dec 2016 | FY | -192.1% | -261.0% | -34.0% | -25.6% | 0.02 | 7.73 | -10.6 |
| 31 Dec 2015 | FY | -326.2% | -462.9% | -36.7% | -29.5% | 0.03 | 9.14 | -9.1 |
| -27.8 |
| 30 Sept 2024 | Q3 | 98.5% | -43.9% | -18.0% | -4.7% | 1.51 | 3.32 | -26.0 |
| 30 Jun 2024 | Q2 | 91.9% | -36.2% | -15.6% | -4.2% | 2.31 | 3.71 | -34.3 |
| 31 Mar 2024 | Q1 | 91.7% | 92.7% | 28.7% | 8.6% | 1.92 | 3.76 | 16.7 |
| 31 Dec 2023 | Q4 | 97.5% | -154.1% | -84.9% | -10.6% | 5.93 | 3.76 | -12.7 |
| 30 Sept 2023 | Q3 | 92.0% | -236.4% | -66.0% | -12.1% | 0.62 | 4.09 | -5.7 |
| 30 Jun 2023 | Q2 | 96.0% | -230.7% | -42.7% | -12.0% | 0.37 | 4.80 | -7.2 |
| 31 Mar 2023 | Q1 | 95.0% | -204.7% | -31.3% | -10.6% | 0.29 | 5.21 | -5.2 |
| 31 Dec 2022 | Q4 | 87.5% | -409.1% | -30.8% | -11.8% | 0.47 | 5.71 | -4.1 |